期刊文献+

重复神经刺激在肌萎缩侧索硬化和重症肌无力患者的应用比较 被引量:4

Application of Repetitive Nerve Stimulation in Patients with Amyotrophic Lateral Sclerosis and Myasthenia Gravis:A Comparative Study
原文传递
导出
摘要 目的:比较重复神经刺激(RNS)应用于肌萎缩侧索硬化(ALS)和重症肌无力(MG)患者的特点及临床意义。方法:收集2013年12月至2015年8月就诊于我院,临床确诊或拟诊型ALS患者和临床诊断的MG患者,比较远、近端神经低频RNS时,复合肌肉动作电位(CMAP)波幅及其异常递减,对两组患者诊断性评估的价值。结果:1 ALS患者68例、MG 52例,RNS阳性者分别为37例(54.4%)、34例(65.4%),两组总阳性率无差异(χ2=0.993,P=0.319)。2RNS阳性率在ALS组的尺、副神经分别为4.4%、51.5%(χ2=6.972,P=0.000),MG组尺、正中、面、副神经15.4%、38.7%、58.0%、65.4%(χ2=30.152,P=0.000)。3RNS递减幅度(%)在ALS和MG组的尺神经分别为15.5±7.5、30.4±8.4(t=2.699,P=0.024),副神经18.2±7.1、27.3±10.7(t=17.442,P=0.000)。4ALS组中RNS阳性和阴性亚组,病情进展速度1.5±1.0、1.0±0.9(t=2.11,P=0.039);尺神经运动波幅(mV)为5.0±3.4、7.0±3.0(t=-2.496,P=0.016),正中神经2.8±2.4、4.6±2.7(t=-2.993,P=0.004)。结论:ALS患者中RNS递减反应者高达50%以上,但递减幅度不如MG;RNS阳性及运动反应波幅低提示ALS病情进展速度快,有助于预后的随访评估。 Objective: To evaluate the features and clinical significance of repetitive nerve stimulation (RNS) in patients with amyotrophic lateral sclerosis (ALS) and myasthenia gravis (MG). Methods: The consecutive patients with definite or probable ALS and patients with MG, referral to our department during December 2013 and August 2015, were enrolled. RNS examination was performed for all patients and EMG examinmion only for ALS patients. Results: @Among the erjrolled 68 ALS and 52 MG, there were 37 and 34 cases showed positive RNS, in which the total positive rates of RNS were 54.4% and 65.4%, respectively, with no significant difference (X2 = 0.993, P=0.319). @The positive rates of ulnar and accessory nerves were 4.4% and 51.5% (X2= 6. 972,P=0.000) in ALS patients; those of ulnar, median, facial and accessory nerves were 15.4%, 38.7%, 58.0% and 65.4%0 (Z2=30.152, P=0.000) in MG patients, respective-ly. @The decremental extent (%) for ulnar nerve was 15.5±7.5 and 30.4±8.4 (t=2. 699, P= 0. 024), for accessory nerve 18.2±7.1 and 27.3±10.7 (t=17. 442, P=0. 000) in ALS and MG patients, respectively. The rate of disease progression was 1.5±1.0 and 1.0±0.9 (t=2.11, P=0. 039) CMAP amplitudes (mV) of ulnar nerve were 5.0±3.4 and 7.0!3.0 (t=-2. 496, progression more rapidly, which would be helpful for follow-up assessment of the prognosis.
出处 《武汉大学学报(医学版)》 CAS 2016年第2期317-321,共5页 Medical Journal of Wuhan University
基金 湖北省卫计委重点项目(编号:WJ2015MA007) 武汉市科技局2015年应用基础研究计划项目(编号:2015060101010047)
关键词 肌萎缩侧索硬化 重症肌无力 重复神经刺激 递减反应 Amyotrophic Lateral Sclerosis Myasthenia Gravis Repetitive Nerve Stimula-tion Decremental Response
  • 相关文献

参考文献26

  • 1Brooks BR,Miller RG,Swash M,et al.World Federation of Neurology Research Group on Motor Neuron Diseases.El Escorial revisited:revised criteria for the diagnosis of amyotrophic lateral sclerosis[J].Amyotroph Lateral Scler Other Motor Neuron Disord,2000,1(5):293-299.
  • 2Meriggioli MN,Sanders DB.Autoimmune myasthenia gravis:emerging clinical and biological heterogeneity[J].Lancet Neurol,2009,8(5):475-490.
  • 3Cedarbaum JM,Stambler N,Malta E,et al.The ALSFRS-R:a revised ALS functional rating scale that incorporates assessments of respiratory function.BDNF ALS Study Group(PhaseⅢ)[J].J Neurol Sci,1999,169(1-2):13-21.
  • 4Traynor BJ,Zhang H,Shefner JM,et al.Functional outcome measures as clinical trial endpoints in ALS[J].Neurology,2004,63(10):1 933-1 935.
  • 5王文华,罗瑛,解燕春,初红,董红娟,肖哲曼,卢祖能.尺神经与正中神经复合肌肉动作电位波幅比值在运动神经元病变中的诊断价值[J].中华神经科杂志,2013,46(5):304-307. 被引量:8
  • 6de Carvalho M,Dengler R,Eisen A,et al.Electrodiagnostic criteria for diagnosis of ALS[J].Clin Neurophysiol,2008,119(3):497-503.
  • 7American Association of Electrodiagnostic Medicine.Guidelines in electrodiagnostic medicine[J].Muscle Nerve,1992,5(2):229-253.
  • 8AAEM Quality Assurance Committee.American Association of Electrodiagnostic Medicine.Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome:summary statement[J].Muscle Nerve,2001,24(9):1 236-1 238.
  • 9Mulder DW,Lambert EH,Eaton LM.Myasthenic syndrome in patients with amyotrophic lateral sclerosis[J].Neurology,1959,9(10):627-631.
  • 10Denys EH,Norris FH Jr.Amyotrophic lateral sclerosis.Impairment of neuromuscular transmission[J].Arch Neurol,1979,36(4):202-205.

二级参考文献39

  • 1傅瑜,樊东升,裴新龙,韩鸿滨,张俊.自然位磁共振影像对平山病的诊断价值[J].中华内科杂志,2006,45(7):573-575. 被引量:37
  • 2傅瑜,樊东升,裴新龙,韩鸿宾,张俊,康德瑄.平山病的MRI诊断[J].中华放射学杂志,2007,41(4):352-355. 被引量:19
  • 3Magnus T, Beck M, Giess R, et al. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve ,2002,25:709-714.
  • 4Kimura F, Fujimura C, Ishida S , et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology, 2006,66 : 265 -267.
  • 5Kaufmann P, Levy G, Thompson JL, et al. The ALSFRSr predicts survival time in an ALS clinic population. Neurology, 2005,64 : 38-43.
  • 6Miller RG, Moore DH 2 nd, Gelinas DF, et al. Phase Ⅲ randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology,2001,56:843-848.
  • 7Cudkowicz ME, Shefner JM, Schoenfeld DA, et al. A randomized, placebo-controlled trial of topiamate in amyotrophic lateral sclerosis. Neurology, 2003,61:456-464.
  • 8Yuen E, Olney R. Longitudinal study of fibre density and motor unit estimates in patients with amytrophic lateral sclerosis. Neurology, 1997,49:573-578.
  • 9Cedarbaum JM, Stambler N, Malta E , et al. The ALSFRS-R : a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group ( phase Ⅲ ). J Neurol Sci, 1999,169 : 13-21.
  • 10Traynor B J, Zhang H, Shefner JM , et al. Functional outcome measures as clinical trial endpoints in ALS. Neurology,2004,63: 1933-1935.

共引文献14

同被引文献25

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部